A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
A study designed to see if the study drug will increase blood levels of vitamin D, bone
mineral density (BMD), improve biochemical markers of bone turnover, and reduce the number of
falls as compared to women receiving standard care for osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Alendronate Calcium Calcium, Dietary Cholecalciferol Ergocalciferols Vitamin D Vitamins